CD45 ([YTH-24 and YTH 54 [anti-CD45 monoclonal antibody Y-90]) and CD52 ([alemtuzumab] CamPath-1H) monoclonal antibody conditioning regimen for allogeneic donor stem cell transplantation of patients With Fanconi anemia
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Alemtuzumab; Anti-CD45 monoclonal antibody Y-90; Fludarabine
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Acronyms MAFIA
- 24 May 2018 Biomarkers information updated
- 18 Jun 2012 Actual patient number 5 added as reported by ClinicalTrials.gov.
- 18 Jun 2012 Actual patient number 5 added as reported by ClinicalTrials.gov.